Humana Inc. Files 8-K for Regulation FD Disclosure

Ticker: HUM · Form: 8-K · Filed: 2025-10-02T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, disclosure

TL;DR

Humana filed an 8-K for a Reg FD disclosure on Oct 2, 2025.

AI Summary

Humana Inc. filed an 8-K on October 2, 2025, reporting a Regulation FD Disclosure. The filing does not contain specific financial transactions or material events beyond this disclosure type.

Why It Matters

This filing indicates Humana Inc. is making a public disclosure under Regulation Fair Disclosure, ensuring all investors receive the same material information simultaneously.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not appear to contain information about significant financial events or changes in business operations.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure made by Humana Inc. on October 2, 2025.

When was this 8-K filing made?

The 8-K filing was made as of October 2, 2025, and the date of the earliest event reported is also October 2, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, KY 40202.

What is Humana Inc.'s telephone number?

Humana Inc.'s telephone number is 502-580-1000.

What is Humana Inc.'s IRS Employer Identification Number?

Humana Inc.'s IRS Employer Identification Number is 61-0647538.

From the Filing

0000049071-25-000048.txt : 20251002 0000049071-25-000048.hdr.sgml : 20251002 20251002120003 ACCESSION NUMBER: 0000049071-25-000048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251002 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20251002 DATE AS OF CHANGE: 20251002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 251367565 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20251002.htm 8-K hum-20251002 0000049071 false 0000049071 2025-10-02 2025-10-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K                  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  October 2, 2025 (October 2, 2025) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 1-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street Louisville , KY 40202 (Address of principal executive offices, including zip code) 502 - 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01    Regulation FD Disclosure. Supplementary Audio Commentary Supplementary audio commentary from Humana’s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/. 2026 Medicare Advantage Star Ratings Based on preliminary 2026 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare and Medicaid Services (CMS), which was inadvertently accessible on CMS Plan Finder for a period of time on October 1, 2025, Humana Inc. (“the Company”) has approximately 1.2 million, or 20%, of its members currently enrolled in

View on Read The Filing